-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: FDA letter in regard to terbutaline as a tocolytic From: Michael J. Wolpmann, M.D. (elvis@llano.net) Tue Dec 30 22:33:45 1997 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: DoctorJoe: "Re: Nubain" Previous message: Garry E. Siegel, M.D.: "GEN: laptop" In reply to: Luis Sanchez-Ramos: "Re: FDA letter in regard to terbutaline as a tocolytic" Next in thread: Dr Eberhard W Lisse: "Re: FDA letter in regard to terbutaline as a tocolytic" Reply: Dr Eberhard W Lisse: "Re: FDA letter in regard to terbutaline as a tocolytic" Reply: Luis Sanchez-Ramos: "Re: Adverse effects of terbutaline: response to Dr. Joe" At Tue, 30 Dec 1997, Luis Sanchez-Ramos wrote: > >At Tue, 30 Dec 1997, Dr Eberhard W Lisse wrote: >> >>In message , Luis Sanchez-Ramos writes: >>[...] >> >>> So most recently we have been notified that MgSO4 infusion as a >>> tocolytic can lead to increased perinatal mortality and that we should >>> not be using terbutaline, especially via the infusion pump. >> >>This is called evidence based medicine :-)-O >> >>el >I do not totally agree. It may be the first step towards evidence based >medicine. The small trial from Chicago which was stopped after an >interim analysis will not answer the question, it will lead to larger >trials. As for terbutaline via SQ pump, only one randomized trial >exists (nB patients): randomized to SQ terb (n) SQ placebo (n) >PO terb (n). This is hardly evidence based medicine! > >L. Sanchez-Ramos I think Dr. Lisse was being facetious...lighten up Luis, I think you are going into labor over this preterm labor thread. -- Michael Michael J. Wolpmann, M.D., FACOG "Chew a little Juicy Fruit, it's good for the soul." Jimmy Buffett Next message: DoctorJoe: "Re: Nubain" Previous message: Garry E. Siegel, M.D.: "GEN: laptop" In reply to: Luis Sanchez-Ramos: "Re: FDA letter in regard to terbutaline as a tocolytic" Next in thread: Dr Eberhard W Lisse: "Re: FDA letter in regard to terbutaline as a tocolytic" Reply: Dr Eberhard W Lisse: "Re: FDA letter in regard to terbutaline as a tocolytic" Reply: Luis Sanchez-Ramos: "Re: Adverse effects of terbutaline: response to Dr. Joe"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:26:06 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.